Johnson & Johnson
NYSE: JNJ
$155.47
-$1.26 (-0.8%)
Closing Price on November 8, 2024
JNJ Articles
After Momenta Pharmaceuticals announced that it would be acquired by pharmaceutical giant Johnson & Johnson, the biotechnology company's shares soared on Wednesday.
Published:
Johnson & Johnson has announced that it will launch its human study for its lead vaccine candidate in the United States and Belgium.
Published:
Credit Suisse has assembled its favorite health care recovery stocks for a recovering base of elective surgeries and for the risk of rising hospitalizations that go well beyond COVID-19.
Published:
If you are a bond and income investor now, times are grim. One analyst says that the best income portfolio now very well may be a collection of high-quality stocks that pay dependable dividends.
Published:
Many investors feel like the key stocks in the market have simply gotten away from them, but those fears are perhaps misguided, according to some key analysts.
Published:
Stocks were looking for direction on Monday ahead of this week’s earnings deluge. With an election coming up and with what is still a very deep recession, investors need to be considering how they...
Published:
Johnson & Johnson released better than expected quarterly results and guidance before the markets opened on Thursday.
Published:
Here, 24/7 Wall St. offers a preview of what to expect from Delta Air Lines, Netflix, PepsiCo and some of the other most anticipated quarterly results due this week.
Published:
Johnson & Johnson has announced that it will accelerate initiation of its early stage first-in-human clinical trial for the treatment of COVID-19. Shares got a mild boost on Wednesday from the news.
Published:
These five very conservative Dividend Aristocrat stocks may offer nervous investors some shelter from the storm if markets head south again.
Published:
Here are 20 bold companies that have defied the odds by raising their dividends, after already knowing they were facing a very deep recession.
Published:
These five stocks could be big winners if the recovery is W-shaped and we and we return to the March lows before turning higher. They also have had substantial insider buying recently, a good sign...
Published:
Even in the toughest times, some companies still manage to generate dividend growth and prove that they have safe dividends. These 15 companies have announced dividend hikes in April.
Published:
Tuesday's top analyst upgrades and downgrades included AT&T, Cognex, Johnson & Johnson, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero Energy and Walt Disney.
Published:
These four top companies are raising dividends into one of the most unpredictable and volatile markets we have seen in years. For investors looking for ideas, these are all incredible companies that...
Published: